After treated with cisplatin, the volume and weight of URGCP/URG4-overexpressing tumors were markedly higher compared to the tumors formed by control cells, indicating the anti-apoptosis function of URGCP/URG4 on bladder cancer cells in vivo (Figure 4A–4C). Here, URGCP is linked to urinary bladder carcinoma.